✦ LIBER ✦

A phase II study of the gamma-secretase inhibitor avagacestat (BMS-708163) in predementia Alzheimer's disease

✍ Scribed by Coric, Vlad; Salloway, Stephen; van Dyck, Christopher; Kerselaers, Wendy; Kaplita, Stephen; Curtis, Craig; Ross, Joel; Richter, Ralph W.; Andreasen, Niels; Brody, Mark; Sharma, Sanjiv K.; Cedarbaum, Jesse M.; Berman, Robert

Book ID: 122365401
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 56 KB
Volume: 9
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2013.05.569

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cerebral microbleeds in a phase 2 clinic

Cerebral microbleeds in a phase 2 clinical trial of mild-to-moderate Alzheimer's disease with the gamma secretase inhibitor BMS-708163

✍ Feldman, Howard; Coric, Vlad; Sperling, Reisa; Greenberg, Steven; Bronen, Richar 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Safety and tolerability of BMS-708163 in

Safety and tolerability of BMS-708163 in a phase II study in mild-to-moderate Alzheimer's disease

✍ Salloway, Stephen; Coric, Vlad; Brody, Mark; Andreasen, Niels; van Dyck, Christo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 82 KB

The gamma-secretase inhibitor BMS-708163

The gamma-secretase inhibitor BMS-708163 causes dose-dependent reductions in CSF Aβ40 levels in patients with mild-to-moderate Alzheimer's disease (AD)

✍ Charles Albright; Niels Andreasen; Lennart Minthon; Kaj Blennow; Howard Feldman; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Safety and Tolerability of the γ-Secreta

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

✍ Coric, Vladimir; van Dyck, Christopher H.; Salloway, Stephen; Andreasen, Niels; 📂 Article 📅 2012 🏛 American Medical Association 🌐 English ⚖ 239 KB

Baseline CSF BETA-AMYLOID 42 correlates

Baseline CSF BETA-AMYLOID 42 correlates with ApoE genotype and baseline cognitive status in a phase II avagacestat predementia Alzheimer's disease study

✍ Soares, Holly; Berisha, Flora; Gleason, Carol; Green, George; Tiller, Jane; Picc 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Three cases of apparent Vasogenic Edema

Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS-708163 in patients with mild-to-moderate AD

✍ Sperling, Reisa; Bronen, Richard; Greenberg, Steven; Sorensen, A. Gregory; Sallo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB